CN103596577B - 包含脂肪组织来源的分泌物的组合物在制备用于局部治疗或预防个体中痤疮的药物中的用途 - Google Patents

包含脂肪组织来源的分泌物的组合物在制备用于局部治疗或预防个体中痤疮的药物中的用途 Download PDF

Info

Publication number
CN103596577B
CN103596577B CN201280022199.7A CN201280022199A CN103596577B CN 103596577 B CN103596577 B CN 103596577B CN 201280022199 A CN201280022199 A CN 201280022199A CN 103596577 B CN103596577 B CN 103596577B
Authority
CN
China
Prior art keywords
adipose tissue
derived
adipocytes
cell
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201280022199.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN103596577A (zh
Inventor
格雷厄姆·维赛
丽贝卡·安妮·韦伯斯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Ideas Pty Ltd
Original Assignee
Cell Ideas Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011900932A external-priority patent/AU2011900932A0/en
Application filed by Cell Ideas Pty Ltd filed Critical Cell Ideas Pty Ltd
Priority to CN201611149524.2A priority Critical patent/CN106581067B/zh
Publication of CN103596577A publication Critical patent/CN103596577A/zh
Application granted granted Critical
Publication of CN103596577B publication Critical patent/CN103596577B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
CN201280022199.7A 2011-03-15 2012-03-15 包含脂肪组织来源的分泌物的组合物在制备用于局部治疗或预防个体中痤疮的药物中的用途 Expired - Fee Related CN103596577B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611149524.2A CN106581067B (zh) 2011-03-15 2012-03-15 药物组合物及其局部用途

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2011900932A AU2011900932A0 (en) 2011-03-15 Pharmaceutical compositions and topical use thereof
AU2011900932 2011-03-15
AU2012900140 2012-01-13
AU2012900140A AU2012900140A0 (en) 2012-01-13 Pharmaceutical compositions and topical use thereof
PCT/AU2012/000274 WO2012122604A1 (en) 2011-03-15 2012-03-15 Pharmaceutical compositions and topical use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201611149524.2A Division CN106581067B (zh) 2011-03-15 2012-03-15 药物组合物及其局部用途

Publications (2)

Publication Number Publication Date
CN103596577A CN103596577A (zh) 2014-02-19
CN103596577B true CN103596577B (zh) 2017-02-15

Family

ID=46829963

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201280022199.7A Expired - Fee Related CN103596577B (zh) 2011-03-15 2012-03-15 包含脂肪组织来源的分泌物的组合物在制备用于局部治疗或预防个体中痤疮的药物中的用途
CN201611149524.2A Expired - Fee Related CN106581067B (zh) 2011-03-15 2012-03-15 药物组合物及其局部用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201611149524.2A Expired - Fee Related CN106581067B (zh) 2011-03-15 2012-03-15 药物组合物及其局部用途

Country Status (8)

Country Link
US (2) US9730964B2 (cg-RX-API-DMAC7.html)
EP (2) EP2685993B9 (cg-RX-API-DMAC7.html)
JP (3) JP6038821B2 (cg-RX-API-DMAC7.html)
CN (2) CN103596577B (cg-RX-API-DMAC7.html)
AU (1) AU2012229890B2 (cg-RX-API-DMAC7.html)
CA (1) CA2865652C (cg-RX-API-DMAC7.html)
DK (1) DK3156060T3 (cg-RX-API-DMAC7.html)
WO (1) WO2012122604A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201606745XA (en) * 2011-09-23 2016-10-28 Cell Ideas Pty Ltd Therapeutics using adipose cells and cell secretions
JP2023002772A (ja) * 2011-09-23 2023-01-10 レジニアス リミテッド 脂肪細胞および細胞分泌物を使用する治療
US20160220479A1 (en) * 2013-09-12 2016-08-04 Ohio State Innovation Foundation Topical compounds containing adipose-derived hormones for the rejuvenation of skin
WO2016013352A1 (ja) * 2014-07-23 2016-01-28 学校法人日本大学 脱分化脂肪細胞の製造方法
IT201700102994A1 (it) * 2017-09-14 2019-03-14 Genlife Sagl Catalizzatore rigenerativo di tessuti e relativo procedimento di realizzazione
KR20230117627A (ko) 2017-10-02 2023-08-08 히로타로 후쿠오카 두피 혹은 피부의 개질, 창상 치유, 또는 모발의 개질에이용되기 위한 의약 조성물
KR102649069B1 (ko) * 2018-05-31 2024-03-19 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물
WO2024151321A2 (en) * 2022-08-05 2024-07-18 Trustees Of Tufts College Systems and methods for commercial scale cultured adipose tissue production
DE202023002794U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC Kassette zur Herstellung einer regenerativen epidermalen Suspension
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1352696A (zh) * 1999-03-10 2002-06-05 匹兹堡大学联邦制高等教育 脂肪来源的干细胞和网格

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296099A (en) * 1976-11-30 1981-10-20 L'oreal Process for extracting embryonic calf skin and pharmaceutical compositions containing the same
US5762947A (en) * 1997-05-09 1998-06-09 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic skin conditioning compositions containing a salicyloxy α-carboxy acid
IT1309453B1 (it) * 1999-10-01 2002-01-23 Consorzio Per Gli Studi Uni Substrato bioartificiale per la realizzazione di tessuti e organianimali, in particolare umani.
AU2002360788A1 (en) 2001-12-31 2003-07-24 Isolagen Technologies, Inc. Hair follicle growth
ES2375565T3 (es) * 2003-08-07 2012-03-02 Healor Ltd. Composiciones farmacéuticas y métodos para acelerar la cicatrización de heridas.
AU2004280616A1 (en) 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
WO2007026356A2 (en) * 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
FR2894961B1 (fr) * 2005-12-16 2008-05-16 Oreal Utilisation de ceramides pour depigmenter la peau
CN101400787B (zh) * 2006-01-27 2013-01-23 株式会社Prostemics 采用脂肪来源成体干细胞大量制造生长因子的方法
US20100092432A1 (en) * 2006-08-08 2010-04-15 Takenori Ozaki Cell preparation containing multipotential stem cells originating in fat tissue
AU2007320031B2 (en) * 2006-10-06 2013-05-02 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
KR101220239B1 (ko) * 2008-04-01 2013-01-09 바이오스펙트럼 주식회사 식물성 펩톤을 포함하는 줄기세포 증식 촉진용 조성물
KR100994133B1 (ko) 2008-04-15 2010-11-15 송신혜 문양이 삽입된 유리 제품 및 이의 제조 방법
FR2938334A1 (fr) 2008-11-13 2010-05-14 Galderma Res & Dev Modulateurs de l'adfp dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
WO2011043136A1 (ja) 2009-10-08 2011-04-14 国立大学法人名古屋大学 脂肪組織由来間葉系幹細胞を含有する免疫抑制剤及びその用途
AU2009251017A1 (en) * 2009-12-17 2011-07-07 Regeneus Ltd. Therapeutic methods
KR100995133B1 (ko) * 2010-02-10 2010-11-18 허쉬바이오주식회사 지방조직 유래 줄기세포 및 단핵구로부터 세포성장인자의 생산방법 및 그 이용
KR101749218B1 (ko) 2010-04-26 2017-06-20 (주)프로스테믹스 양모 효과를 가지는 인간 지방유래 줄기세포의 조건 배지 및 이의 용도
US20120195969A1 (en) * 2010-09-29 2012-08-02 Aidan Research And Consulting, Llc Treatment of acne by conditioned media

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1352696A (zh) * 1999-03-10 2002-06-05 匹兹堡大学联邦制高等教育 脂肪来源的干细胞和网格

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
痤疮的发病机理及其治疗药物;孙秘书; 任慧霞;;《2008年中国药学会学术年会暨第八届中国药师周》;20081231;573-577 *
脂肪组织分泌功能研究进展;苏丽清;《国外医学老年医学分册》;20050930;第26卷(第5期);228-231 *

Also Published As

Publication number Publication date
HK1191557A1 (zh) 2014-08-01
EP2685993B9 (en) 2017-04-05
EP2685993B1 (en) 2016-08-17
JP2017031214A (ja) 2017-02-09
JP6038821B2 (ja) 2016-12-07
US20180169151A1 (en) 2018-06-21
CN103596577A (zh) 2014-02-19
JP2018080205A (ja) 2018-05-24
US10967008B2 (en) 2021-04-06
CN106581067B (zh) 2021-07-23
AU2012229890B2 (en) 2015-02-26
JP2014511827A (ja) 2014-05-19
EP2685993A1 (en) 2014-01-22
CA2865652C (en) 2020-12-29
AU2012229890A1 (en) 2013-05-02
US20140087001A1 (en) 2014-03-27
EP2685993B8 (en) 2016-10-19
CN106581067A (zh) 2017-04-26
US9730964B2 (en) 2017-08-15
EP2685993A4 (en) 2014-11-19
DK3156060T3 (da) 2019-11-25
CA2865652A1 (en) 2012-09-20
EP3156060A1 (en) 2017-04-19
EP3156060B1 (en) 2019-11-06
WO2012122604A1 (en) 2012-09-20
JP6621853B2 (ja) 2019-12-18

Similar Documents

Publication Publication Date Title
JP6621853B2 (ja) 医薬組成物およびその局所使用
US10660921B2 (en) Therapeutics using adipose cells and cell secretions
AU2015202776B2 (en) Pharmaceutical compositions and topical use thereof
AU2013203164B8 (en) Therapeutics for skin conditions
HK1236414A1 (en) Pharmaceutical compositions and topical use thereof
HK1236414A (en) Pharmaceutical compositions and topical use thereof
HK1236414B (en) Pharmaceutical compositions and topical use thereof
HK1191557B (en) Composition adipose tissue-derived secretions for use in the topical treatment or prevention of acne
HK40015513A (en) Therapeutics using adipose cells and cell secretions
AU2019203058A1 (en) Stem cells and secretions for treatment of inflammatory conditions

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170215